NWK Group’s AstraZeneca AZN Stock Holding History

NWK Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,387	Closed	-$2.78M	–	204
2020 Q3	$2.78M	Buy	25,387 +672	+3%	+$74.7K	1.37%	26
2020 Q2	$2.61M	Buy	+24,715	New	+$2.55M	1.49%	27

Other funds holding AZN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NWK Group's AZN Position: Q4 2020 in Review

NWK Group sold out of AstraZeneca (AZN) in Q4 2020, closing a stake of 25,387 shares — an estimated $2.78M sold.

NWK Group first reported a position in AZN in Q2 2020 and held it in 2 quarters. The position peaked at $2.78M in Q3 2020. 785 funds tracked by Wall St. Rank hold AZN as of Q4 2020.

NWK Group reported no remaining AstraZeneca position as of Q4 2020 after selling out during the quarter.
NWK Group sold 25,387 AstraZeneca shares in Q4 2020, an estimated $2.78M.
NWK Group first reported a position in AstraZeneca in Q2 2020 and held it in 2 quarters.
NWK Group's AstraZeneca position peaked at $2.78M in Q3 2020.
785 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2020.

Based on NWK Group's 13F filing for Q4 2020, filed 10 Feb 2021.